Home
Our Experts
Become an Expert
Ask A Question
PharmaLive
Pharmalot
Ask A Question
The * denotes a required field.
Ask A Question
Your Name
*
Email
*
Job Title
Topic
Patient Support Programs
Accelerated Proof-of-Concept
Cardiac Safety in Early Phase
Drug Delivery Technologies
Imaging
Subject
Question
*
Archives
Select Month
May 2230 (2)
May 2011 (4)
December 2010 (4)
November 2010 (2)
September 2010 (2)
April 2010 (4)
March 2010 (2)
February 2010 (2)
January 2010 (6)
October 2009 (4)
September 2009 (2)
August 2009 (2)
July 2009 (4)
April 2009 (2)
Our Experts
Alan Copa, PharmD
David M. Oakley, R.Ph., Ph.D.
Graham Wood, PhD
Richard Walovitch, Ph.D.
Our Current Topics
Accelerated Proof-of-Concept
Cardiac Safety in Early Phase
Drug Delivery Technologies
Imaging
Recent Questions
How do you get an accurate baseline QT measurement and still take increased heart rate into account?...
What are the most critical elements in designing a thorough QT trial?...
What considerations should be given to the collection of multiple measurements at the same time points?...
What role does calculating the supratherapeutic dose for a central nervous system compound delivered orally play in study timelines?...
What additional factors need to be considered when an intravenous or injectable delivery method is used in a TQT trial?...
When determining the supratherapeutic dose, what are the most critical steps?...
Can you explain the logistical challenges of staggered dosing across cohorts?...
